Occult hepatitis B virus infection in Thai blood donors

Transfusion

Volumn 51, Issue 7, 2011, Pages 1532-1540

  Louisirirotchanakul, Suda ^a,b,c,d,e   Oota, Sineenart ^a,b,c,d,e   Khuponsarb, Kalayanee ^a,b,c,d,e   Chalermchan, Wilai ^a,b,c,d,e   Phikulsod, Soisaang ^a,b,c,d,e   Chongkolwatana, Viroje ^a,b,c,d,e   Sakuldamrongpanish, Tasanee ^a,b,c,d,e   Kitpoka, Pimpun ^a,b,c,d,e   Chielsilp, Pimol ^a,b,c,d,e   Tanprasert, Srivilai ^a,b,c,d,e   Tirawatnapong, Thaweesak ^a,b,c,d,e   Wasi, Chantapong ^a,b,c,d,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d MINISTRY OF PUBLIC HEALTH   (Thailand)

^e KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; MALE; NUCLEIC ACID AMPLIFICATION; REINFECTION; SEROLOGY; VIRUS LOAD;

BLOOD DONORS; DIAGNOSTIC ERRORS; DNA, VIRAL; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MASS SCREENING; NUCLEIC ACID AMPLIFICATION TECHNIQUES; SEROLOGIC TESTS; THAILAND; VIRAL LOAD;

EID: 79960182413     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03023.x     Document Type: Article

References (31)

1. Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Praphan Phanuphak P, Wasi C, Nuchprayoon C,; The Working Group for NAT Study in Thai Blood Donations. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations. Transfusion 2009; 49: 1126-35.
2. Allain J-P,. Occult hepatitis B infection: implications in transfusion. Vox Sang 2004; 86: 83-91. (Pubitemid 38436885)
3. Raimondo G, Pollicino T, Cacciola I, Squadrito G,. Occult hepatitis B infection. J Hepatol 2007; 46: 160-70.
4. Van Hemert FJ, Zaaijer HL, Berkhout B, Lukashov VV,. Occult hepatitis B infection: an evolutionary scenario. Virol J 2008; 5: 146-58.
5. Hollinger FB,. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion 2008; 48: 1001-26. (Pubitemid 351614923)
6. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K,. Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007; 47: 1197-205. (Pubitemid 46934327)
7. Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain J-P,. Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol 2008; 48: 1022-5.
8. Dettori S, Candido A, Kondili LA, Chionne P, Taffon S, Genovese D, Iudicone P, Miceli M, Rapicetta M,. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors. J Infec 2009; 59: 128-33.
9. Luksamijarulkul P, Thammata N, Tiloklurs M,. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 272-9.
10. Ishida T, Takao S, Settheetham-Ishida W, Tiwawech D,. Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand. J Clin Virol 2002; 24: 31-5. (Pubitemid 34016011)
11. Liu CJ, Chen DS, Chen PJ,. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006; 36: S33-44.
12. Comanor L, Holland P,. Hepatitis B virus blood screening; unfinished agendas. Vox Sang 2006; 91: 1-12. (Pubitemid 43822298)
13. Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Lin Tsai SJ,. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infection and closing the serologic window for hepatitis C virus. Transfusion 2008; 48: 1198-206. (Pubitemid 351793490)
14. Wiwanitkit V,. Anti HCV seroprevalence among the voluntary blood donors in Thailand. Hematol J 2005; 10: 431-3. (Pubitemid 41806535)
15. Linauts S, Saldanha J, Strong DM,. PRISM hepatitis B surface antigen detection of hepatitis B virus minipool nucleic acid yield samples. Transfusion 2008; 48: 1376-82.
16. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A,. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 2009; 81: 815-25.
17. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M,. Italian blood donors with anti-HBc and occult hepatitis B infection. Hematol J 2007; 92: 1664-70. (Pubitemid 350248246)
18. Torbenson M, Thomas DL,. Occult hepatitis B. Lancet 2002; 2: 479-86. (Pubitemid 34826853)
19. Lui CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS,. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. J Hepatol 2006; 44: 39-46.
20. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayer-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ,. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus. Transfusion 2008; 48: 1558-66.
21. Reesink HW, Engelfriet CP, Henn G, Mayr WR, Delage G, Bernier F, Krusius T, Assal A, Gallian P, Corbi C, Morel P, David B, De Micco P, Murokawa H, Yugi H, Hino S, Tadokoro K, Flesland O, Brojer E, Letowska M, Olim G, Nascimento F, Gonsalves H, Castro L, et al,. Occult hepatitis B infection in blood donors. Vox Sang 2008; 94: 153-66.
22. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE,. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007; 47: 1803-8. (Pubitemid 47438545)
23. Mulrooney-Cousins PM, Michalak TI,. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol 2007; 13: 5682-6. (Pubitemid 350120219)
24. Yoshikawa A, Gotanda Y, Itabashi M, Minegishi K, Nishioka K,; The Japanese Red Cross NAT Screening Research Group. Hepatitis B NAT virus-positive donors in the early and late stages of HBV infection: analyses of the WP and kinetics of HBV DNA. Vox Sang 2005; 88: 77-86. (Pubitemid 40362922)
25. Yoshikawa A, Gotanda Y, Minegishi K, Taira R, Hino S, Tadokoro K, Ohnuma H, Miyakawa K, Tachibana K, Mizoguchi H,; The Japanese Red Cross NAT Screening Research Group. Length of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute phase. Transfusion 2007; 47: 1162-71. (Pubitemid 46934305)
26. Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH, Glebe D,. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion 2009; 49: 1621-9.
27. Chudy M, Schmidt M, Czudai V, Scheiblauer H, Nick S, Mosebach M, Hourfar MK, Seifried E, Roth WK, Grunelt E, Nubling CM,. Hepatitis B virus genotype G monoinfection and its transmission by blood components. Hepatology 2006; 44: 99-107. (Pubitemid 44049143)
28. Togashi H, Hashimoto C, Yokozawa J, Suzuki A, Sugahara K, Saito T, Yamaguchi I, Badawi H, Kainuma N, Aoyama M, Ohya H, Akatsuka T, Tanaka Y, Mizokami M, Kawata S,. What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? J Hepatol 2008; 49: 17-24.
29. Satoh K, Iwata-Takakura A, Yoshikawa A, Gotanda Y, Tanaka T, Yamaguchi T, Mizoguchi H,. A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection. Vox Sang 2008; 95: 174-80.
30. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC,. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004; 86: 28-40. (Pubitemid 38200453)
31. Borkent-Raven BA, Janssen MP, van der Poel CL, de Wit GA, Bonsel GJ, van Hout BA,. Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands. Transfusion 2009; 49: 311-9.